Concepedia

Tracey Hall

TH

Statistics

Publications

5

Citations

538

H-Index

5

Active since

2013

Affiliations

Millennium Engineering and Integration (United States)(Current)

Jena University Hospital

Memorial Sloan Kettering Cancer Center

King's College Hospital NHS Foundation Trust

Jagiellonian University

Tracey Hall is an author at Millennium Engineering and Integration (United States) specializing in medicine, pharmacology, and chronic myeloid leukemia therapy.

Publications per year

2013–2022

5

Publications

5

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

Carole Scherling, Tracey Hall, Flora Berisha et al. · Annals of Neurology · 2013 · 252 citations · Full text

, , +17

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

Jörge E. Cortes, Jane F. Apperley, Elza Lomaia et al. · Blood · 2021 · 193 citations · Full text

, , +6

Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee

James L. Januzzi, Joseph Garasic, Scott E. Kasner et al. · Journal of Hematology & Oncology · 2022 · 66 citations · Full text

, , +9

OPTIC primary analysis: A dose-optimization study of 3 starting doses of ponatinib (PON).

Jörge E. Cortes, Jane F. Apperley, Elza Lomaia et al. · Journal of Clinical Oncology · 2021 · 14 citations

, , +16

Identification and Preclinical Pharmacology of the<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi mathvariant="bold-italic">γ</mml:mi></mml:mrow></mml:math>-Secretase Modulator BMS-869780

Jeremy H. Toyn, Lorin A. Thompson, Kimberley A. Lentz et al. · International Journal of Alzheimer s Disease · 2014 · 13 citations · Full text

, , +17

1–5 of 5